Clinical Advantage
Superior efficacy and safety profile compared to traditional GLP-1 weight loss medications
Side Effect Profile
Based on STEP Clinical Trial Data
Minimal Gastrointestinal Adverse Reactions
Unlike traditional GLP-1 agonists with 18-44% nausea rates, Botagovy® demonstrates excellent tolerability with negligible gastrointestinal side effects.
Nausea
Vomiting
Diarrhea
Constipation
The Botagovy Advantage: Exceptional tolerability means better adherence and sustained results.
Muscle Preservation
The Critical Differentiator
Protect Your Metabolic Engine
Unlike traditional weight loss medications where 25-40% of weight loss comes from lean muscle mass, Botagovy® helps preserve or even increase muscle while losing fat.
The Muscle Loss Problem
Why Losing Muscle Matters
Decreased BMR
Muscle tissue burns more calories at rest than fat. Losing muscle slows your metabolism.
Weight Regain Risk
Lower metabolic rate makes it easier to regain weight after stopping medication.
Reduced Strength
Loss of lean mass impacts physical function and quality of life.
Aging Acceleration
Muscle loss (sarcopenia) accelerates aging and increases frailty risk.
Traditional Weight Loss Drugs
of weight loss from lean mass
Botagovy®
muscle loss or muscle gain
High-Risk Populations
Certain groups are more vulnerable to muscle loss during weight loss:
Elderly
Already experiencing age-related muscle decline
Women
Generally have lower muscle mass to begin with
Low Protein Intake
Insufficient amino acids for muscle maintenance
The Botagovy Solution
Botagovy® promotes fat loss while preserving lean muscle through natural GLP-1 modulation, supporting healthy metabolic function.